Inflammation Panel

Human and Mouse

The Inflammation panel from NanoString is comprised of over 250 genes focused for screening of inflammation response in general immunology research including allergy, auto-immune diseases and infectious disease immune response. The genes included in the panel represent a broad range of relevant pathways related to inflammation, including apoptosis, EGF, interleukin signaling, Ras, T-cell receptor and Toll-like receptor signaling.

Benefits

01

Focused screening for inflammation response in allergy, auto-immune disease and infections disease research.

02

Ideal for the study asthma, arthritis and neurological-related inflammation.

03

Measure gene expression effects of anti-inflammatory drugs on inflammatory response.

Genes in panel

Need CLIA Certified NanoString Services?

Fill out this form and one of our scientists will contact you.

Pricing

mRNA > Inflammation

$4,429.00

Up to 12 samples per order analyzed.

$

Please add some options to render this input.

Step 3

Price

Number of samples
$4,429.00*
*price includes reagents
REQUEST A QUOTE
SKU: inflammation. Categories: , , . Tag:
Genes: ..
.................................................................................................................................................................................................................................................................................
Aliases: .................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................
Tag: